AMSBIO has launched a new set of dedicated webpages and content downloads detailing their extensive range of GMP-compliant products and services.

Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group.

Waters Corporation today announced expanded powder rheology capabilities for its TA Instruments HR Rheometers allowing scientists to make repeatable powder rheology measurements.

On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.

AMSBIO has published an interview with Professor Marius Wernig that discusses what could be the world’s first widely applicable curative treatment for Epidermolysis Bullosa.

Cherwell Laboratories has confirmed its continued support for the Pharmaceutical & Healthcare Sciences Society (PHSS) Annual Conference 2022.

Thermo Fisher Scientific Inc. is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges.

Bio-Rad Laboratories, Inc. has introduced a range of type 1 antibodies that inhibit the binding of evolocumab to its target, human proprotein convertase subtilisin/kexin type 9, a protein that has been shown to play a key role in the regulation of cholesterol levels.

Beckman Coulter Life Sciences announces a partnership with Flownamics to create an automated, on-line solution for bioprocess culture monitoring and control.

VectorBuilder Inc. has announced that its partnership with cell and gene therapy company Lantu Biopharma has led to the first human trial of an innovative gene therapy drug candidate for Menkes disease.